BURLINGTON, Mass., Oct. 15, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it will host an Investor Day on Wednesday, December 10, 2025, at the Company's biorepository facility ...
BURLINGTON, Mass., April 7, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the appointment of Trey Martin as President of its Multiomics business, effective April 6, 2026. In this ...
Azenta Life Sciences is committed to helping customers reach new heights in their pursuit of scientific progress. Discover enterprise-wide sample exploration and management solutions to accelerate ...
BURLINGTON, Mass., Feb. 10, 2023 /PRNewswire/ -- Azenta, Inc. (AZTA) today announced that Company management will participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ...
BURLINGTON, Mass., Jan. 23, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has been selected as the technology provider by UK Biocentre as they expand their large-scale ...
Business: Azenta is a life sciences company that operates through two segments. First, there's the life sciences products division, which offers automated cold sample management systems for compound ...
Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities
BURLINGTON, Mass., March 4, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, Azenta UK Ltd, has ...
Shares of Azenta, Inc. (AZTA) have fallen to fresh lows again amidst quite some corporate developments taking place. By now, shares have fallen to the $20 mark, levels first broken to the upside in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results